{"schema_version":"1","generated_at":"2026-11-08T05:29:44.706Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mark-schray","json_url":"https://www.findmykol.com/kol/mark-schray/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mark-schray","name":"Mark Schray","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Legacy Health","institution_url":"https://www.findmykol.com/institution/legacy-health","city":"Portland","state":"OR","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1063400752","openalex":"A5084118564"},"summary":"Mark Schray is an Oncology physician affiliated with Legacy Health. OpenAlex indexes 49 publications with 2,728 citations (h-index 27).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":49,"cited_by_count":2728,"h_index":27,"latest_activity_year":2016,"source":"works"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Genitourinary & hormones","share_pct":100,"classes_total":1,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":100,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":9.8,"facility_pct":90.2},"source":"medicare"},"publications":{"total":49,"shown":5,"withheld":44,"matched_by":"OpenAlex author record","recent":[{"title":"Prophylactic use of pentoxifylline (Trental) and vitamin E to prevent capsular contracture after implant reconstruction in patients requiring adjuvant radiation","year":2016,"journal":"The American Journal of Surgery","source_url":"https://doi.org/10.1016/j.amjsurg.2016.01.006","status":"verified"},{"title":"Experience with partial breast irradiation for treatment of breast cancer at a community-based cancer center","year":2014,"journal":"The American Journal of Surgery","source_url":"https://doi.org/10.1016/j.amjsurg.2013.12.025","status":"verified"},{"title":"Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation","year":2003,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/s0090-8258(03)00199-9","status":"verified"},{"title":"Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma","year":2002,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/s0360-3016(02)02947-4","status":"verified"},{"title":"Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation","year":1994,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/0360-3016(94)90142-2","status":"verified"}],"source":"works"},"similar":[{"name":"Steven Mansberger","slug":"steven-mansberger","institution":"Legacy Health","specialty":"Glaucoma Specialist","url":"https://www.findmykol.com/kol/steven-mansberger","json_url":"https://www.findmykol.com/kol/steven-mansberger/profile.json"},{"name":"John McAnulty","slug":"john-mcanulty","institution":"Legacy Health","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/john-mcanulty","json_url":"https://www.findmykol.com/kol/john-mcanulty/profile.json"},{"name":"Claude Burgoyne","slug":"claude-burgoyne","institution":"Legacy Health","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/claude-burgoyne","json_url":"https://www.findmykol.com/kol/claude-burgoyne/profile.json"},{"name":"William Shults","slug":"william-shults","institution":"Legacy Health","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/william-shults","json_url":"https://www.findmykol.com/kol/william-shults/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":44}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}